CHP
ALDR

Cable Hill Partners’s Alder Biopharmaceuticals ALDR Stock Holding History

Cable Hill Partners’s Portfolio ALDR Stock Details ALDR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-13
Closed – – 1000
2017
Q4 		$0 Sell
13
-174
-93% -$1.94K ﹤0.01% 1060
2017
Q3 		$2K Sell
187
-5
-3% -$52 ﹤0.01% 952
2017
Q2 		$2K Sell
192
-1
-0.5% -$18 ﹤0.01% 702
2017
Q1 		$4K Buy
193
+168
+672% +$3.72K ﹤0.01% 606
2016
Q4 		$1K Sell
25
-181
-88% -$4.71K ﹤0.01% 711
2016
Q3 		$6K Sell
206
-11
-5% -$335 ﹤0.01% 542
2016
Q2 		$6K Hold
217
– – ﹤0.01% 487
2016
Q1 		$6K Sell
217
-6
-3% -$139 ﹤0.01% 463
2015
Q4 		$8K Hold
223
– – 0.01% 402
2015
Q3 		$8K Sell
223
-4
-2% -$170 0.01% 423
2015
Q2 		$12K Hold
227
– – 0.01% 410
2015
Q1 		$6K Buy
+227
New +$6.23K ﹤0.01% 546

Other funds holding ALDR

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FCMI
Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return